← Volver a resultados
Ficha bibliográfica · Consulta y acceso
Artículo

Exosome Therapy for Livedoid Vasculitis Following COVID-19 Vaccination: A Case Report

Lin TK et al · Dove Medical Press · 2026

Acceso abierto al texto completo
Lectura rápida. Revisá los datos básicos del recurso y luego accedé al contenido desde el botón principal. En esta ficha solo se muestra la información necesaria para identificar la obra, citarla y abrirla.

Acceso al recurso

Entrá al contenido desde la opción principal o elegí otra fuente disponible.

Acceso principal

Acceso abierto al texto completo

DOAJ DOAJ - Open Access Journals
Texto completo identificado como acceso abierto.
Abrir texto

Resumen

Descripción general del contenido del recurso.

Tsung-Kun Lin,1,2,* Chih-Feng Chang,3,* Gwo-Ping Jong4,5 1Department of Pharmacy, Tri-Service General Hospital, Taipei, Taiwan, Republic of China; 2School of Pharmacy, National Defense Medical University, Taipei, Taiwan, Republic of China; 3Division of Cardiology, Department of Internal Medicine, Taichung Armed Force General Hospital, Taichung, Taiwan, Republic of China; 4Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan, Republic of China; 5School of Medicine, Chung Shan Medical University, Taichung, Taiwan, Republic of China*These authors contributed equally to this workCorrespondence: Gwo-Ping Jong, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan, Republic of China, Email cgp8009@yahoo.com.twAbstract: Livedoid vasculitis is a vascular autoimmune disorder affecting the skin. It most commonly occurs in young women. The occurrence of this condition after the coronavirus 2019 (COVID-19) vaccination is rare. The available literature suggests limited use of exosomes in the treatment of livedoid vasculitis. We present the case of a 65-year-old Chinese man who developed livedoid vasculitis after COVID-19 vaccination. We posit that the etiology in this case may be either COVID-19 vaccine-induced immune stimulation or activation of the condition by a rare vaccine component. This case is unique, with no previously reported precedents. The patient was treated intravenously for 1 month with stem cell-derived exosome therapy, using stem cells derived from exfoliated human deciduous teeth. This resulted in improvement in the livedoid vasculitis, with no reemergence of symptoms. This case highlights the therapeutic benefits of exosome treatment for livedoid vasculitis after COVID-19 vaccination. However, large-scale studies are needed before this outcome can be generalized.Keywords: livedoid vasculitis, COVID-19 vaccination, exosomes, elderly, exfoliated human deciduous teeth

Cómo citar

Elegí el formato que necesitás y copiá la referencia al portapapeles.

APA 7

al, L. T. E. (2026). Exosome Therapy for Livedoid Vasculitis Following COVID-19 Vaccination: A Case Report. https://www.dovepress.com/exosome-therapy-for-livedoid-vasculitis-following-covid-19-vaccination-peer-reviewed-fulltext-article-DHPS

MLA

al, Lin TK et. "Exosome Therapy for Livedoid Vasculitis Following COVID-19 Vaccination: A Case Report." 2026. https://www.dovepress.com/exosome-therapy-for-livedoid-vasculitis-following-covid-19-vaccination-peer-reviewed-fulltext-article-DHPS.

Chicago

al, Lin TK et. 2026. "Exosome Therapy for Livedoid Vasculitis Following COVID-19 Vaccination: A Case Report.". https://www.dovepress.com/exosome-therapy-for-livedoid-vasculitis-following-covid-19-vaccination-peer-reviewed-fulltext-article-DHPS.

Harvard

al, L. T. E. 2026, Exosome Therapy for Livedoid Vasculitis Following COVID-19 Vaccination: A Case Report, Dove Medical Press, available at: https://www.dovepress.com/exosome-therapy-for-livedoid-vasculitis-following-covid-19-vaccination-peer-reviewed-fulltext-article-DHPS [Accessed 23 Jun. 2026].

Compartir e imprimir

Guardá la ficha, copiá su enlace permanente o imprimila como PDF.

Exportar referencia

Si usás un gestor bibliográfico, podés exportar el registro en los formatos más comunes.

Detalles del recurso

Información bibliográfica útil para confirmar que se trata del material correcto.

Título
Exosome Therapy for Livedoid Vasculitis Following COVID-19 Vaccination: A Case Report
Autor / colaboradores
Lin TK et al
Editorial
Dove Medical Press
Año de publicación
2026
ISSN
1179-1365
ISSN
1179-1365
Idioma
eng

Materias

Explorá otros recursos relacionados a partir de estas materias.

Copiado